Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-09-17

Clinical Trial Update: DESIR. Evaluation of the Pre-therapeutic Activity of Dihydropyrimidine dEShydrogenase (DPD) in Patients With Cancer and/or Renal Failure

View source ↗

Summary

Clinical trial evaluating pre-therapeutic dihydropyrimidine dehydrogenase (DPD) activity in cancer patients with renal impairment to inform dosing; status is no…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Centre Hospitalier Universitaire de Besancon | Conditions: Renal Impairment, Digestive Cancers | Status: NOT_YET_RECRUITING